Document is current
Any future updates will be listed below
-
Authors
Xu, Bichun
Zhao, Xianzhi
Chen, Di
Zhao, Wenjuan
Wang, Xiaoyan
Ding, Changhua
Yuan, Zhiyong
Zhang, Huojun
-
Funding
Funding for this research was provided by:
the First Affiliated Hospital of Navy Medical University “234 Subject Climbing Program” (2019YPT004)
- License Information
-
More Information
Article History
Received: 14 September 2022
Accepted: 6 January 2023
First Online: 21 January 2023
Declarations
:
: Prior to the enrollment and treatment, all patients signed an informed consent form and received thorough information from their oncologists regarding to the potential toxicity and benefits of SBRT. This retrospective study was reviewed and approved by the Ethics Committees of both Shanghai Changhai Hospital of the Navy Medical University and Tianjin Medical University Cancer Institute and Hospital, it was conducted according to the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
